Chronic hepatitis C and B-cell non-Hodgkin's lymphoma. 1996

C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
Istituto Patologia Medica I, University of Pisa, Italy.

Hepatitis C virus (HCV), a hepatotropic and lymphotropic virus, is the major causative agent of nonA-nonB chronic hepatitis; moreover, it is frequently associated with benign and malignant lymphoproliferative disorders such as mixed cryoglobulinaemia and B-cell non-Hodgkin's lymphoma (NHL). We investigated the clinical and virological features of B-cell NHL complicating chronic hepatitis C in a series of 10 patients (M/F 1/9; mean age 63 +/- 6SD years). The malignancy appeared after median 8 +/- 4SD years from onset and was low-grade in six patients, intermediate in three, and high-grade in one. 'One-tube nested' PCR detected serum HCV RNA and viral ongoing replication in both fresh and cultured peripheral lymphocytes in all ten. Analysis of HCV genotypes showed a relatively higher prevalence of 2a/III type compared with unselected chronic hepatitis C (50% vs. 15%). In one patient, HCV RNA was also found in the neoplastic bone marrow and lymph-node specimens. B-cell NHL can complicate chronic hepatitis C and affect the overall prognosis of the disease. The increasing frequency of chronic hepatitis C worldwide suggests that the actual prevalence of this complication may be underestimated. Careful clinical work-up at diagnosis and during follow-up is particularly recommendable.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
December 2002, Clinical lymphoma,
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
July 2016, World journal of gastroenterology,
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
December 2000, Orvosi hetilap,
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
September 2014, The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi,
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
March 2015, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology,
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
November 2011, World journal of hepatology,
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
March 2000, The American journal of medicine,
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
September 1999, Hepatology (Baltimore, Md.),
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
February 2000, Internal medicine (Tokyo, Japan),
C Ferri, and L La Civita, and M Monti, and C Giannini, and R Cecchetti, and F Caracciolo, and G Longombardo, and F Lombardini, and A L Zignego
August 2004, International journal of cancer,
Copied contents to your clipboard!